Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

NCT01515748 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

530

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Docetaxel (XRP6976)
DRUG: Oxaliplatin (SR96669)
DRUG: S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)

Sponsor

Sanofi